Winton Group LTD Biogen Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $146,154 - $164,958	577 Added 38.83%	2,063 $530,000
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $3.19 Million - $3.69 Million	-11,605 Reduced 88.65%	1,486 $423,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $967,487 - $1.1 Million	-3,771 Reduced 22.36%	13,091 $3.64 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $2.43 Million - $2.95 Million	9,609 Added 132.48%	16,862 $4.67 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $1.41 Million - $1.95 Million	7,253 New	7,253 $1.94 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $279,803 - $352,538	-1,444 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $323,340 - $415,539	1,444 New	1,444 $346,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $2.7 Million - $4.06 Million	-11,422 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$264.77 - $305.71 $2.6 Million - $3 Million	-9,827 Reduced 46.25%	11,422 $3.24 Million
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $4.82 Million - $6.38 Million	18,631 Added 711.65%	21,249 $5.69 Million
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $703,849 - $892,842	2,618 New	2,618 $828,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $11.1 Million - $15.3 Million	-50,246 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $1.84 Million - $2.07 Million	8,479 Added 20.3%	50,246 $11.7 Million
Q2 2019 Jul 08, 2019	BUY	$219.29 - $241.72 $1.13 Million - $1.25 Million	5,164 Added 14.11%	41,767 $9.77 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $7.76 Million - $12.1 Million	35,825 Added 4604.76%	36,603 $8.65 Million
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $52,915 - $67,022	-190 Reduced 19.63%	778 $234,000
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $48,722 - $63,715	-166 Reduced 14.64%	968 $0
Q2 2018 Aug 20, 2018	SELL	$257.52 - $306.91 $93,994 - $112,022	-365 Reduced 24.35%	1,134 $0
Q1 2018 May 21, 2018	SELL	$260.13 - $367.91 $3,121 - $4,414	-12 Reduced 0.79%	1,499 $0
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $7.91 Million - $8.86 Million	-25,703 Reduced 94.45%	1,511 $481,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $4.69 Million - $5.5 Million	16,696 Added 158.74%	27,214 $8.52 Million
Q2 2017 Aug 17, 2017	BUY	N/A	10,518	10,518 $2.85 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account